ArticleMethods in molecular biology (Clifton, N.J.)2026
Optimized Retinal Cell Dissociation for Downstream Analysis of Cone Photoreceptors.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The isolation of viable and homogenous retinal cells is essential for downstream molecular analysis, such as single-cell sequencing and transcriptomics. However, the dissociation of retinal cells can be challenging due to the intricate nature of retinal tissue and the fragility of its cells. Furthermore, cone photoreceptors are highly susceptible to degeneration. We developed an optimized protocol for retinal cell dissociation that improves the quality of cones for downstream molecular analysis. Our protocol employs a papain enzymatic digestion, mechanical dissociation, and filtration to obtain a high percentage of viable cells with minimal cell death and damage. This protocol is a reliable and efficient method for downstream molecular analysis of cones and other retinal cells which can be useful for disease modeling-in which target cells are already sensitive and in a degenerative state-and examining the effects of treatments such as gene replacement therapies.
Indexed as
Identifiers
42020900What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.